aminolevulinic acid has been researched along with Cystadenocarcinoma, Papillary in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As a peritoneal surface malignancy, primary peritoneal papillary serous carcinoma (PPPSC) almost always occurs in women." | 1.40 | Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case. ( Canbay, E; Endo, Y; Hirano, M; Ishibashi, H; Kitai, T; Mizumoto, A; Nishino, E; Ogura, S; Sako, S; Yonemura, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canbay, E | 1 |
| Ishibashi, H | 1 |
| Sako, S | 1 |
| Kitai, T | 1 |
| Nishino, E | 1 |
| Hirano, M | 1 |
| Mizumoto, A | 1 |
| Endo, Y | 1 |
| Ogura, S | 1 |
| Yonemura, Y | 1 |
1 other study available for aminolevulinic acid and Cystadenocarcinoma, Papillary
| Article | Year |
|---|---|
Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case.
Topics: Administration, Oral; Aminolevulinic Acid; Combined Modality Therapy; Cystadenocarcinoma, Papillary; | 2014 |